Europe Press. The 2017 financial bill, recently approved by the Senate of the Republic of Italy, includes notable provisions that favor biosimilar drugs, a significant milestone that will increase competition among biotech drug companies.
Industry news
Europe Press. The 2017 financial bill, recently approved by the Senate of the Republic of Italy, includes notable provisions that favor biosimilar drugs, a significant milestone that will increase competition among biotech drug companies.
recently published
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.